Financhill
Back

Viking Therapeutics Stock Price Chart

  • The current trend is relatively stagnant and VKTX is experiencing slight buying pressure.

Viking Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 26.59 Buy
20-day SMA: 27.13 Buy
50-day SMA: 27 Buy
200-day SMA: 40.91 Sell
8-day EMA: 26.98 Buy
20-day EMA: 27.05 Buy
50-day EMA: 27.36 Buy
200-day EMA: 35.95 Sell

Viking Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 55.12 Buy
Chaikin Money Flow: 1072308 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.2 - 28.12) Buy
Bollinger Bands (100): (24.9 - 30.3) Buy

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Viking Therapeutics Stock

Is Viking Therapeutics Stock a Buy?

VKTX Technical Analysis vs Fundamental Analysis

Sell
32
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?

Viking Therapeutics Stock Info

Market Cap:
3.2B
Price in USD:
28.17
Share Volume:
5.4M

Viking Therapeutics 52-Week Range

52-Week High:
81.73
52-Week Low:
18.92
Sell
32
Viking Therapeutics (VKTX) is a Sell

Viking Therapeutics Share Price Forecast

Is Viking Therapeutics Stock a Buy?

  • Viking Therapeutics share price is 28.17 while VKTX 8-day exponential moving average is 26.98, which is a Buy signal.
  • The stock price of VKTX is 28.17 while Viking Therapeutics 20-day EMA is 27.05, which makes it a Buy.
  • Viking Therapeutics 50-day exponential moving average is 27.36 while VKTX share price is 28.17, making it a Buy technically.
  • VKTX stock price is 28.17 and Viking Therapeutics 200-day simple moving average is 35.95, creating a Sell signal.

Fundamental Analysis of Viking Therapeutics

Is Viking Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.64 per share.

Technical Analysis of Viking Therapeutics

Should I short Viking Therapeutics stock?

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.